Bioequivalence Centres in Africa: Current State and Opportunities For Growth
March 11, 2026
The promise of strengthening regulatory systems through building Bioequivalence Centres across the African continent.
As pharmaceutical manufacturing continues to expand across Africa, so does the demand for Bioequivalence centres capable of generating reliable data to support regulatory decision-making. However, the continent faces gaps in BE infrastructure, technical capacity, and regulatory requirements.
In a recent open-access article published in Journal of Pharmaceutical Policy and Practice, experts from Market Access Africa examine the current landscape of Bioequivalence centres across the continent.
The analysis highlights an opportunity to strengthen Africa’s regulatory systems through increasing the number of bioequivalence centers across the continent to meet the growing ambition of local pharmaceutical production. In addition, it calls for the development of university-accredited bioequivalence training programmes, and requiring African national medicines regulatory authorities to mandate demonstration of bioequivalence for generic medicines from both domestic and foreign applicants. These efforts should increase access to life-saving health products and technologies.
Read the full article here: https://doi.org/10.1080/20523211.2025.2522483
